ArticleNAR genomics and bioinformatics2026
IsoformSwitchAnalyzeR v2: analysis of functional isoform changes in long-read and single-cell sequencing data.
Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SpliceImpactR maps alternative RNA processing events driving protein functional diversity.Nucleic acids research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alternative splicing enables a single gene to produce a variety of mRNA transcripts, significantly enhancing protein diversity in higher eukaryotes. Isoform switching refers to the differential usage of a gene's transcripts and occurs pervasively across physiological and pathological conditions. IsoformSwitchAnalyzeR was developed to identify these isoform switches and analyze their functional consequences. Advances in RNA-seq technology, including long-read and single-cell sequencing, along with state-of-the-art computational tools, enable unprecedented accuracy in isoform switch identification and its functional consequences, necessitating an update to IsoformSwitchAnalyzeR. Here, we present IsoformSwitchAnalyzeR 2.0, with substantial improvements in the robustness of isoform switch detection, the incorporation of new functional annotation types, and interoperability with other bioinformatics tools. We showcase how IsoformSwitchAnalyzeR's standard workflow is now well-suited for analysis of both long-read RNA-seq and single-cell data through two case studies. Specifically, we analyze long-read data from patients with Alzheimer's disease and single-cell data from patients with glioblastoma. In both case studies, we find important isoform switches with disease-relevant functional consequences, showcasing the power of IsoformSwitchAnalyzeR v2. Taken together, these findings highlight the versatility and robustness of IsoformSwitchAnalyzeR in handling advanced sequencing technologies, thereby broadening its applicability across diverse research contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.